Supernus Pharmaceuticals SUPN Cash ratio
Cash ratio at other companies
Other financials
Where this comes from
Calculated from Supernus Pharmaceuticals’s reported figures.
Based on the most recent quarter.
The official record: Supernus Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Supernus Pharmaceuticals's cash ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Supernus Pharmaceuticals's cash ratio?
- Supernus Pharmaceuticals (SUPN) reported cash ratio of 0.5× in Q1 2026.
- How has Supernus Pharmaceuticals's cash ratio changed year-over-year?
- Supernus Pharmaceuticals's cash ratio increased by 21.2% year-over-year, from 0.4× to 0.5×.
- What is the long-term trend for Supernus Pharmaceuticals's cash ratio?
- Over 5 years (2020 to 2025), Supernus Pharmaceuticals's cash ratio has grown at a -20.1% compound annual growth rate (CAGR), from 1.2× to 0.4×.
- What does cash ratio mean?
- Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.